stockrowThermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.
- Revenue
- +9.13%
- EPS
- +8.64%
- Free cash flow
- +15.0%
- Total debt
- +22.8%
Quarter to September 2026, against a year earlier
Follow TMO
Alert me
Thermo Fisher Scientific Inc. (TMO) Operating cash flow
Thermo Fisher Scientific Inc.'s operating cash flow for fiscal 2025 was $7.8B, down 9.80% from $8.7B in fiscal 2024. Over the twelve months to 30 September 2026 it was $9.3B. Over the past ten years it has ranged from $2.9B (fiscal 2015) to $9.3B (fiscal 2021); the current reading is higher than 55% of that period. Thermo Fisher Scientific Inc. ranks 1st of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $7.8B | (9.80%) |
| FY2024 | $8.7B | 3.10% |
| FY2023 | $8.4B | (8.17%) |
| FY2022 | $9.2B | (1.70%) |
| FY2021 | $9.3B | 12.34% |
| FY2020 | $8.3B | 66.68% |
| FY2019 | $5.0B | 9.47% |
| FY2018 | $4.5B | 13.43% |
| FY2017 | $4.0B | 22.93% |
| FY2016 | $3.3B | 10.74% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $2.6B | 20.00% |
| Jun 2026 | $2.1B | 78.27% |
| Mar 2026 | $1.2B | (65.52%) |
| Dec 2025 | $3.5B | 54.40% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| TMO Thermo Fisher Scientific Inc. | $9.3B |
| DHR Danaher Corporation compare | $6.9B |
| IQV IQVIA Holdings Inc. compare | $2.7B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.2B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $460.6M |
| NTRA Natera, Inc. compare | $212.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement